by admin | Mar 31, 2024 | Antibodies, Glymab
Bryony Heath, Elena Dubinina, Foram Dave, Ruhul H. Choudhury, Omar Mohammed, Bubacarr Kaira, Poonam Vaghela, Tina Parsons, Mandeep Sehmi, Mireille Vankemmelbeke and Lindy G. Durrant by admin | Nov 30, 2023 | Antibodies, Glymab
GlyMabs® for T cell redirection by chantal | Sep 25, 2023 | Antibodies, Avidimab, Glymab, Moditope, Vaccines
Seventh International Cancer Immunotherapy Conference (CICON23), Milan, September 2023 Unlocking the unique potential of AvidiMab® in fighting cancer Bubacarr G Kaira, Foram Dave, Elena Dubinina, Omar Mohammed, Bryony Heath, Poonam Vaghela, Ruhul Choudhury, Tina... by admin | Nov 16, 2022 | Antibodies, Avidimab
Bubacarr G Kaira, Foram Dave, Elena Dubinina, Omar Mohammed, Bryony Heath, Poonam Vaghela, Ruhul Choudhury, Tina Parsons, Samantha Paston and Mireille Vankemmelbeke and Lindy G. Durrant by admin | Oct 28, 2022 | Antibodies, Avidimab, Glymab
EuroMAbNet 6th Antibody Validation Workshop and 12th Meeting, Hamburg, 22-24 September 2022 Unlocking the unique potential of AvidiMAb® in fighting cancer Bubacarr G Kaira, Foram Dave, Elena Dubinina, Omar Mohammed, Bryony Heath, Poonam Vaghela, Ruhul Choudhury, Tina... by admin | Feb 14, 2022 | Antibodies, Glymab
Ruben D. Houvast, Kira Thijse, Jesse V. Groen, JiaXin Chua, Mireille Vankemmelbeke, Lindy G. Durrant, J. Sven D. Mieog, Bert A. Bonsing, Alexander L. Vahrmeijer, Peter J.K. Kuppen, A. Stijn L.P. Crobach and Cornelis F. M. Sier SIMPLE SUMMARY: Distinguishing pancreatic...